Everolimus for Compassionate Use in Multiple Basal Cell Carcinomas
Everolimus is an inhibitor of the mammalian target of rapamycin (mTOR) and has been shown to have antineoplastic activity in addition to its use as an immunosuppressive agent for the prevention of organ transplant rejection. We report the use of everolimus for the compassionate treatment of four eld...
Saved in:
Main Authors: | Laura Eibenschutz, Delia Colombo, Caterina Catricalà |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Case Reports in Dermatological Medicine |
Online Access: | http://dx.doi.org/10.1155/2013/604301 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiple Basal Cell Carcinomas Arising in Nevus Sebaceous
by: Ugnè Tiskeviciute, et al.
Published: (2025-01-01) -
Metastatic Basal Cell Carcinoma: A Biological Continuum of Basal Cell Carcinoma?
by: Karaninder S. Mehta, et al.
Published: (2012-01-01) -
Focus on Basal Cell Carcinoma
by: Venura Samarasinghe, et al.
Published: (2011-01-01) -
Stem Cell Therapy: A Compassionate Use Program in Perianal Fistula
by: M. D. Herreros, et al.
Published: (2019-01-01) -
Basal Cell Carcinoma Masked in Rhinophyma
by: Daniele De Seta, et al.
Published: (2013-01-01)